Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Incyte Corp (NASDAQ:INCY)

113.48
Delayed Data
As of Oct 23
 -0.71 / -0.62%
Today’s Change
83.01
Today|||52-Week Range
153.15
+13.17%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Baker Bros Advisors Lp
Director
Buy9/08/201785,402$132.00$11.3M-12.34%
Hoppenot Herve
Chairman & Chief Executive Officer
Sale9/18/201770,502$119.45$8.4M-4.16%
Friedman Paul A
Director
Sale3/17/201741,693$148.18$6.2M-23.30%
Friedman Paul A
Director
Sale2/23/201750,000$120.32$6.0M-6.95%
Gryska David W
Chief Financial Officer & Executive Vice President
Sale4/10/201739,789$138.00$5.5M-17.10%
Hoppenot Herve
Chairman & Chief Executive Officer
Sale2/24/201732,443$121.95$4.0M-13.51%
Stein Steven H
Chief Medical Officer & Executive Vice President
Sale4/07/201727,000$137.88$3.7M-19.01%
Brooke Paul Alan
Director
Sale3/17/201720,000$147.75$3.0M-23.30%
Swain Paula J
EVP-Human Resources
Sale8/31/201720,000$140.00$2.8M-17.42%
Gryska David W
Chief Financial Officer & Executive Vice President
Buy4/10/201739,789$67.06$2.7M-17.10%
Page of 15